Mondo Visione Worldwide Financial Markets Intelligence
Track all markets on TradingView

FTSE Mondo Visione Exchanges Index:

News Centre

BT_Radianz_468x60_Jul23

  • Ramy Aziz To Retire As ASX Chief Financial Officer

    Date 18/06/2018

    ASX announces that its Chief Financial Officer, Mr Ramy Aziz, will retire in September 2018, after 18 years of service with the Group, including eight years as CFO.

  • SET Rolls Out YFS 2018 Competition To Groom Young Financial Professionals

    Date 18/06/2018

    The Stock Exchange of Thailand (SET), in collaboration with capital market alliances, holds the Young Financial Star Competition 2018 (YFS 2018) for the 16th consecutive year, aiming at grooming university-level youth for quality professionals and investors in the capital market with number of participants this year increasing to  6,677 candidates, the highest ever, from 80 universities nationwide.

  • SGX Welcomes Astrea IV Private Equity Bond Retail Offering

    Date 18/06/2018

    Singapore Exchange (SGX) today welcomed the listing of Astrea IV private equity (PE) Class A-1 bonds issued by Azalea Group, an indirect wholly owned subsidiary of Temasek Holdings. The issuance marks the first such structure in Singapore for retail investors to subscribe to PE bonds.  

  • Trust Is The Missing Link In Today's Cryptocurrencies, BIS Says

    Date 17/06/2018

    Cryptocurrencies' model of generating trust limits their potential to replace conventional money, the Bank for International Settlements (BIS) writes in its Annual Economic Report (AER), a new title launched this year.

  • Members Of Pluristem’s Management Opened The Trading On TASE To Mark The Announcement Of Positive Results In A Clinical Study Among Intermittent Claudication Sufferers

    Date 17/06/2018

     

    ​This morning, June 17, 2018, members of Pluristem’s management opened the trading to mark the announcement of positive results in a Phase II clinical study among Intermittent Claudication sufferers. Pluristem has developed innovative technology for growing placenta-based stem cells and for their use in treating a variety of conditions, such as inflammation, orthopedic injuries and hermatological disorders The leading product developed by the company is intended for the treatment of severe Intermittent Claudication in the lower limbs.

Confinity_sky1-min.gif BT_Radianz_120x600_Jul23.jpg